ACRV – acrivon therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season? [Yahoo! Finance]
While institutions own 26% of Acrivon Therapeutics, Inc. (NASDAQ:ACRV), private equity firms are its largest shareholders with 50% ownership [Yahoo! Finance]
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its price target raised by analysts at BMO Capital Markets from $18.00 to $25.00. They now have an "outperform" rating on the stock.
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its price target raised by analysts at JMP Securities from $14.00 to $17.00. They now have a "market outperform" rating on the stock.
Form EFFECT Acrivon Therapeutics,
Form ARS Acrivon Therapeutics, For: Dec 31
Form DEFA14A Acrivon Therapeutics,
Form DEF 14A Acrivon Therapeutics, For: Jun 20
Form 8-K Acrivon Therapeutics, For: Apr 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.